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A 1 year old male infant is brought to the pediatrician by his
mother because of a copious nasal discharge and developmen-
tal delay. He is noted to have coarse features with thick lips, a
large tongue, a large bulging head and a ﬂattened nose. On
examination he is found to have an enlarged liver and spleen.
His perinatal history was unremarkable. He was born by nor-
mal vaginal delivery and was examined and thought to be nor-
mal at birth.
A likely diagnosis is:
(a) Osteopetrosis.
(b) b thalassemia.
(c) Achondroplasia.
(d) Hurler’s syndrome.
(e) Rickets.Diagnosis is (d) Hurler’s syndrome
Examples of other case presentations with Hurler’s syndrome
Clinical presentation [1]
A 3 year old female presented in an outpatient Pediatric Clinic
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ated problems included delayed speech development, hearing
impairment, and knock knees. At 6 months of age, her parents
observed she did not look normal hence they conﬁned her in-
doors most of the time. None of her other siblings (four) had
similar problems. On examination she had coarse facies with
frontal bossing, bilateral corneal clouding and depressed nasal
bridge. She had copious nasal discharge. Her apex beat was at
the ﬁfth left intercostal space lateral to the mid clavicular line.
Auscultation of the lung ﬁelds yielded transmitted sounds. The
abdomen was distended with hepatomegaly of 6 cm below the
costal margin in the midclavicular line. She also had short stur-
dy ﬁngers, swelling of both wrists, kyphoscoliosis, and bilateral
genu valgus [1].What was the diagnosis of this case?
A clinical diagnosis of Hurler’s syndrome was made. Urinary
glycosaminoglycans level could not be obtained in the reported
case but alkaline phosphatase level was raised. There were clas-
sical radiological features both of Hurler’s syndrome and rick-
ets. She had vitamin D replacement therapy but absconded
from follow up. A search for this association of Hurler’s syn-
drome with rickets was not easily available in documented lit-
erature hence the need to publish it [1].Clinical presentation [2]
A 2-year-old patient with Hurler’s syndrome underwent
bone marrow transplantation. Although the bone marrow
transplantation improved many of the systemic effects of Hur-
ler’s syndrome, the patient presented at 8 years of age with a
cervical myelopathy. Magnetic resonance imaging revealed
soft tissue compression of the upper cervical cord. The litera-
ture review demonstrates that spastic tetraparesis, secondary
to cervical cord compression, is the most common presentation
of this subgroup of patients.
Table 1 Some MPS I clinical characteristic ﬁndings.
Some MPS I clinical characteristic ﬁndings
Craniofacial dysmorphism in the form of coarse facies, low anterior hair line,
hypertelorism, bilateral medial epicanthal folds, corneal clouding, depressed
nasal bridge, broad nasal tip and anteverted nostrils. The cheeks are full. The lips
are enlarged, and the mouth is held open
Protruded abdomen, wide subcostal angle, downward shift of the umbilical
hernia
Some MPS I radiological characteristic ﬁndings
Hurler syndrome; lateral radiograph of thoracolumbar vertebrae illustrates
vertebral plana. Courtesy of Bruce M. Rothschild, MD [5]
Hurler’s syndrome; widened metaphyses and diaphyses with truncated distal
portions forming a peg characterize this radiograph. Courtesy of Bruce M.
Rothschild, MD [5]
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Mucopolysaccharidoses can induce a compressive metabolic
myelopathy. Decompressive procedures have shown signiﬁcant
improvement in neurological function in the majority of pa-
tients without spinal instability. Bone marrow transplantation
may allow more patients with mucopolysaccharidoses to sur-
vive long enough to require neurosurgical treatment in the fu-
ture. The effect of bone marrow transplantation on the
prevention of spinal cord compression is unclear [2].What are the mucopolysaccharidoses (MPSs)?
The mucopolysaccharidoses (MPSs) are a family of metabolic
disorders caused by the deﬁciency of lysosomal enzymes
needed to degrade glycosaminoglycan (GAG). GAG is an
important constituent of the extracellular matrix, joint ﬂuid,
and connective tissue throughout the body. Progressive accu-
mulation of GAG within the cells of various organs ultimately
compromises their function. The major sites of disease differ
depending on the speciﬁc enzyme deﬁciency; therefore, clinical
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various disease types. Of the MPSs, mucopolysaccharidosis
type I (MPS I) is by far the most common type. MPS I has
a heterogeneous group of manifestations, and the severity of
its symptoms widely varies. The range of the most-to-the least
severe forms of MPS type I is as follows: Hurler’s syndrome,
Hurler–Scheie syndrome, and Scheie syndrome [3].
What causes Hurler’s syndrome
Mucopolysaccharidosis type I (MPS I) is caused by a deﬁciency
of the lysosomal enzyme, a-L-iduronidase. This deﬁciency leads
to accumulation of undegraded mucopolysaccharides, espe-
cially dermatan sulfate, in tissues and organs. The buildup of
excess dermatan sulfate (DS) leads to the gradual development
of numerous morphological abnormalities in tissues and or-
gans. The a-L-iduronidase gene has been mapped to chromo-
some band 4p16.3. The metabolic defect in MPS IH has an
autosomal recessive mode of inheritance [4,5].
What are the recommended investigations for Hurler’s syndrome
[5]
Laboratory studies. The following studies are indicated in pa-
tients with suspected mucopolysaccharidosis type I (MPS I):
 Lymphocytes in the blood smears may be examined for
abnormal cytoplasmic inclusions.
 Urinary levels of the mucopolysaccharides, dermatan sul-
fate (DS) and heparan sulfate (HS), are increased.
 Levels of a-L-iduronidase enzyme may be assayed in cul-
tured ﬁbroblasts and in leukocytes.
 Prenatal diagnosis of the enzyme level may also be made in
amniotic cells and chorionic villi cells.
Imaging studies
 In severe cases of mucopolysaccharidosis type I (MPS I),
radiography of the skeleton (especially the spine) may be
useful for detecting a gibbus deformity of the lower spine.
 Echocardiography is useful in determining the nature of
cardiac complications.
 A characteristic mild dysostosis multiplex can often be
radiologically determined.Other tests
 Other tests for problems in vision, hearing, and heart dis-
ease become necessary as symptoms appear in patients with
mucopolysaccharidosis type I (MPS I).
Is there a treatment for Hurler’s syndrome
The goal of treatment for Hurler’s syndrome is to give the
body the missing enzyme so it can break down the GAGs.
The two main treatments for children with Hurler’s syndrome
are enzyme replacement therapy and a bone marrow or cord
blood transplant.
Enzyme replacement therapy. For enzyme replacement therapy,
a patient is given a drug that has the IDUA enzyme his or her
body is missing. Treatment with the missing enzyme can im-
prove problems with breathing, growth, the bones, joints and
heart.However, there is no evidence that it has any effect on men-
tal development problems caused by Hurler’s syndrome. En-
zyme replacement therapy may be a good option for children
who have a form of MPS I disorder that does not cause mental
retardation (Scheie syndrome or Hurler’s/Scheie syndrome).
Some children with Hurler’s syndrome may be treated with
both enzyme therapy and a transplant. This approach is being
studied in a clinical trial [6] (see Table 1).
Bone marrow or cord blood transplant. A bone marrow or cord
blood transplant (also called a BMT) is the only known treat-
ment that can stop the progression of mental damage caused
by Hurler’s syndrome [7–9].References
[1] ‘Obidike E, Njeze Ngozi R, Ude AC, Nnanni O, Ossi GO. A rare
case report: mucopolysaccharidosis (Hurler syndrome) with rachi-
tic changes in a Nigerian. West Afr J Radiol 2004;11:14–8.
[2] Edward K, Rolando D. Mucopolysaccharidoses and spinal cord
compression: case report and review of the literature with impli-
cations of bone marrow transplantation. Neurosurgery
2000;47:223–9.
[3] Yano S, Moseley K, Pavlova Z. Postmortem studies on a patient
with mucopolysaccharidosis type I: histopathological ﬁndings after
one year of enzyme replacement therapy. J Inherit Metab Dis
2009:27 [Epub ahead of print].
[4] Wraith JE. Mucopolysaccharidoses and oligosaccharidoses. In:
Fernandes J, Saudubray J-M, van den Berghe G, Walter JH,
editors. Inborn metabolic diseases: diagnosis and treatment. New
York, NY: Springer; 2006.
[5] Banikazemi M. Mucopolysaccharidosis type I. <http://www.
emedicine.medscape.com/article/1599374-overview>.
[6] Pastores GM. Laronidase (Aldurazyme): enzyme replacement
therapy for mucopolysaccharidosis type I. Expert Opin Biol Ther
2008;8(7):1003–9.
[7] Peters C, Shapiro EG, Anderson J, et al. Hurler syndrome: II.
Outcome of HLA-genotypically identical sibling and HLA-haplo-
identical related donor bone marrow transplantation in ﬁfty-four
children. The Storage Disease Collaborative Study Group. Blood
1998;91(7):2601–8.
[8] Peters C, Balthazor M, Shapiro EG, et al. Outcome of unrelated
donor bone marrow transplantation in 40 children with Hurler
syndrome. Blood 1996;87:4894–902.
[9] Staba SL, Escolar ML, Poe M, et al. Cord-blood transplants from
unrelated donors in patients with Hurler’s syndrome. N Engl J Med
2004;350:1960–9.
Choose the proper answer for the following MCQs
1. A sequence is deﬁned in dysmorphology by which of the
following?
(a) Multiple anomalies attributed to mutation in a speciﬁc
gene.
(b) Non-random occurrence of multiple anomalies more
often than expected by chance.
(c) Set of anomalies that can be attributed to consequences
of a single aberrant developmental event.
(d) Set of anomalies resulting from damage to a fetal
structure.
(e) None of the above.
2. Failure to produce Mullerian-inhibiting substance in a
genetic male would result in:
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(b) Presence of a uterus.
(c) Breast development at puberty.
(d) Failure of virilization of the phallus.
(e) None of the above.
3. Which of the following would most likely explain a 46,
XX individual with development of testes?
(a) Mutation of SOX9.
(b) Presence of excessive androgen during in utero
development.
(c) Translocation of SRY from the Y to an autosome.
(d) Chimerism with a 46, XY cell line.
(e) None of the above.
4. Cirrhosis occurring in individuals with beta thalassemia
would be a consequence of:
(a) Iron overload.
(b) Chronic anemia.
(c) Toxicity due to chelation therapy.
(d) Hepatitis infection due to transfusion.
(e) None of the above.
5. A major limitation of DNA-based carrier screening in
cystic ﬁbrosis is:
(a) Laboratory errors in mutation analysis.
(b) Non-penetrance of many CFTR mutations.
(c) Germline mosaicism.
(d) Incomplete ascertainment of mutations.
(e) All of the above.
6. Which of the following is used as the mainstay of treat-
ment of hemochromatosis?
(a) Transfusion.
(b) Chelation.
(c) Phlebotomy.
(d) Iron.
(e) None of the above.
7. Tay-Sachs disease carrier screening is most commonly
done by:
(a) Enzyme assay.
(b) DNA-testing.
(c) Analysis of a blood smear.
(d) Ophthalmological testing looking for a cherry-red spot.
(e) All of the above.
8. Testing an individual for HLA haplotype to determine
risk of an autoimmune disease would be an example of
a:
(a) Diagnostic test.
(b) Presymptomatic test.
(c) Predispositional test.
(d) Screening test.
(e) None of the above.
9. The result of a predispositional test is most likely to be
in the form of:
(a) A ‘yes’ or ‘no’ answer to the question of whether an indi-
vidual will develop disease.
(b) A risk limited by recombination between a marker locus
and a disease locus.
(c) A risk ﬁgure based on rate of penetrance.
(d) A relative risk ﬁgure.
(e) None of the above.10. Which of the following is the usual treatment of hemo-
philia A?
(a) Blood transfusion.
(b) Liver transplant.
(c) Bone marrow transplant.
(d) Infusion of factor VIII as needed.
(e) None of the above.
11. Which of the following distinguishes DNA from RNA?
(a) Presence of 30 deoxyribose in DNA, ribose in RNA.
(b) Presence of uracil in RNA in place of thymidine in
DNA.
(c) Occurrence of base pairing in DNA but not RNA.
(d) Presence of 50 phosphate in DNA but not RNA.
(e) None of the above.
12. Manifestations of untreated classic PKU include all the
following except:
(a) Mousy odor of urine.
(b) Fair complexion.
(c) Hepatosplenomegaly.
(d) Irritability.
(e) Exaggerated deep tendon reﬂexes.
13. The enzyme responsible for unwinding DNA during rep-
lication is:
(a) DNA polymerase.
(b) RNA polymerase.
(c) Ligase.
(d) Helicase.
(e) None of the above.
14. Marfan’s syndrome is characterized by all the following
except:
(a) Lens ectopia.
(b) Long arms.
(c) Lack of thrombosis.
(d) Neuropsychologic impairment.
(e) Autosomal recessive.
15. Homocystinuria syndrome is characterized by all the fol-
lowing except:
(a) Lens ectopia.
(b) Long arms.
(c) X linked recessive.
(d) Arterial and venous thrombosis.
(e) Mental retardation.
MCQs answers key
Question No. Answer Question No. Answer
1 c 9 d
2 b 10 d
3 c 11 b
4 a 12 c
5 d 13 d
6 c 14 e
7 a 15 c
8 c
